XML 20 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 203,665 $ 173,719
Restricted cash 1,500 0
Short-term marketable securities 221,893 147,608
Accounts receivable, net of allowance of $778 and $736 as of December 31, 2023 and 2022, respectively 146,226 121,795
Prepaid expenses and other current assets 26,714 30,216
Total current assets 599,998 473,338
Long-term marketable securities 56,644 59,206
Property and equipment, net 32,599 47,428
Operating leases - right of use asset 22,391 33,752
Deferred tax assets, net 62,761 45,412
Intangible assets, net 9,715 12,801
Goodwill 7,447 7,447
Noncurrent restricted cash 1,200 2,700
Other noncurrent assets 19,863 18,857
Total assets 812,618 700,941
Current liabilities:    
Accounts payable 988 2,808
Accrued liabilities 43,096 42,592
Deferred revenues, current 333,267 293,728
Operating lease liabilities, current 11,857 13,060
Total current liabilities 389,208 352,188
Deferred revenues, noncurrent 31,671 23,490
Operating lease liabilities, noncurrent 16,885 29,121
Other noncurrent liabilities 6,680 7,013
Total liabilities 444,444 411,812
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock: $0.001 par value; 20,000 shares authorized, no shares issued and outstanding as of December 31, 2023 and 2022 0 0
Common stock: $0.001 par value; 1,000,000 shares authorized, 36,909 and 37,362 shares issued and outstanding as of December 31, 2023 and 2022, respectively 37 37
Additional paid-in capital 597,921 512,486
Accumulated other comprehensive loss (1,704) (1,947)
Accumulated deficit (228,080) (221,447)
Total stockholders’ equity 368,174 289,129
Total liabilities and stockholders’ equity $ 812,618 $ 700,941